Laboratory for Investigative Dermatology, Rockefeller University, New York, NY, USA.
J Allergy Clin Immunol. 2013 Aug;132(2):361-70. doi: 10.1016/j.jaci.2013.04.046. Epub 2013 Jun 15.
Atopic dermatitis (AD) is classified as extrinsic and intrinsic, representing approximately 80% and 20% of patients with the disease, respectively. Although sharing a similar clinical phenotype, only extrinsic AD is characterized by high serum IgE levels. Because most patients with AD exhibit high IgE levels, an "allergic"/IgE-mediated disease pathogenesis was hypothesized. However, current models associate AD with T-cell activation, particularly TH2/TH22 polarization, and epidermal barrier defects.
We sought to define whether both variants share a common pathogenesis.
We stratified 51 patients with severe AD into extrinsic AD (n = 42) and intrinsic AD (n = 9) groups (with similar mean disease activity/SCORAD scores) and analyzed the molecular and cellular skin pathology of lesional and nonlesional intrinsic AD and extrinsic AD by using gene expression (real-time PCR) and immunohistochemistry.
A significant correlation between IgE levels and SCORAD scores (r = 0.76, P < 10(-5)) was found only in patients with extrinsic AD. Marked infiltrates of T cells and dendritic cells and corresponding epidermal alterations (keratin 16, Mki67, and S100A7/A8/A9) defined lesional skin of patients with both variants. However, higher activation of all inflammatory axes (including TH2) was detected in patients with intrinsic AD, particularly TH17 and TH22 cytokines. Positive correlations between TH17-related molecules and SCORAD scores were only found in patients with intrinsic AD, whereas only patients with extrinsic AD showed positive correlations between SCORAD scores and TH2 cytokine (IL-4 and IL-5) levels and negative correlations with differentiation products (loricrin and periplakin).
Although differences in TH17 and TH22 activation exist between patients with intrinsic AD and those with extrinsic AD, we identified common disease-defining features of T-cell activation, production of polarized cytokines, and keratinocyte responses to immune products. Our data indicate that a TH2 bias is not the sole cause of high IgE levels in patients with extrinsic AD, with important implications for similar therapeutic interventions.
特应性皮炎(AD)分为外源性和内源性,分别代表约 80%和 20%的患者。尽管具有相似的临床表型,但只有外源性 AD 表现为高血清 IgE 水平。由于大多数 AD 患者表现出高 IgE 水平,因此假设其发病机制为“过敏”/IgE 介导。然而,目前的模型将 AD 与 T 细胞激活相关联,特别是 TH2/TH22 极化和表皮屏障缺陷。
我们旨在确定这两种变体是否具有共同的发病机制。
我们将 51 例严重 AD 患者分为外源性 AD(n = 42)和内源性 AD(n = 9)组(具有相似的平均疾病活动度/SCORAD 评分),并通过基因表达(实时 PCR)和免疫组织化学分析来分析病变和非病变内源性 AD 和外源性 AD 的皮肤分子和细胞病理学。
仅在外源性 AD 患者中发现 IgE 水平与 SCORAD 评分之间存在显著相关性(r = 0.76,P < 10(-5))。T 细胞和树突状细胞的明显浸润以及相应的表皮改变(角蛋白 16、Mki67 和 S100A7/A8/A9)定义了两种变体的病变皮肤。然而,在所有炎症轴(包括 TH2)的激活程度在内源性 AD 患者中更高,特别是 TH17 和 TH22 细胞因子。仅在内源性 AD 患者中观察到 TH17 相关分子与 SCORAD 评分之间存在正相关,而仅在外源性 AD 患者中观察到 SCORAD 评分与 TH2 细胞因子(IL-4 和 IL-5)水平之间的正相关以及与分化产物(角蛋白丝和桥粒芯糖蛋白)之间的负相关。
尽管内源性 AD 和外源性 AD 患者之间存在 TH17 和 TH22 激活的差异,但我们确定了 T 细胞激活、极化细胞因子产生以及角质形成细胞对免疫产物反应的共同疾病定义特征。我们的数据表明,TH2 偏向并不是外源性 AD 患者高 IgE 水平的唯一原因,这对类似的治疗干预具有重要意义。